HanAll Biopharma hanall.co.kr


HanAll Biopharma (KRX: 009420) focuses on the research and development of biopharmaceuticals that can be a source of hope for patients with rare and incurable diseases who are suffering from no proper treatment. HanAll Biopharma is researching and developing new antibody drugs with mechanism of action, which is capable of treating various rare autoimmune diseases that occur due to autoantibodies; an anti-TNF bio pharmaceutical, which is developed for inflammatory eye diseases such as dry eye dis...Show all

HanAll Biopharma (KRX: 009420) focuses on the research and development of biopharmaceuticals that can be a source of hope for patients with rare and incurable diseases who are suffering from no proper treatment. HanAll Biopharma is researching and de...Show all

Company (IPO / Went public)

Phone:

Fax:

Daewoong Building 3F
12, Bongeunsa-ro 114-gil, Gangnam-gu
Seoul, 06170
South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
HanAll Biopharma $93.9M May 30, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related HanAll Biopharma Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)